Drugs / Fosmetpantotenate
Fosmetpantotenate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03041116 | Jul 2017 → Dec 2019 | pantothenate kinase-associated neurodegeneration | Travere Therapeutics, Inc. | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fosmetpantotenate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03041116 ↗ |
| Known as | Fosmetpantotenato | ChEMBL registry synonym — accepted as the source's own label CHEMBL6067991 ↗ |
| Known as | RE-024 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6067991 ↗ |